Skip to main content

Table 3 Summary of HCMV-tetramer in HLA-A2 young children

From: Large scale analysis of pediatric antiviral CD8+ T cell populations reveals sustained, functional and mature responses

Age(yr.) (n = 179) < 1 (n = 60) 1 (n = 45) 2 (n = 30) 3 (n = 27) 4 (n = 17)
Number of tet(+) 14(23%) 17(38%) 9(30%) 11(41%) 4(24%)
CD8 18.1 ± 5.1 16.7 ± 4.1 22.5 ± 3.5 19.7 ± 4.4 20.1 ± 5.1
Tet(%) 0.20 ± 0.20 0.25 ± 0.32 0.17 ± 0.19 0.15 ± 0.14 0.08 ± 0.05
Tet/CD8(%) 1.16 ± 1.13 1.48 ± 1.78* 0.73 ± 0.77* 0.75 ± 0.65* 0.28 ± 0.26*
  1. HCMV-tetramer positive: Tet/CD8(+) Lymphocytes ≥ 0.05%
  2. *: P values < 0.05